Floating Button
The Edge Singapore
Sign In
Home Capital Covid-19
Premium
Covid-19

AsiaMedic gets approval to import and administer Sinopharm vaccine

Amala Balakrishner
Amala Balakrishner • 1 min read
AsiaMedic gets approval to import and administer Sinopharm vaccine
The vaccines will be available for six months starting Sep 30
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Two clinics under the AsiaMedic group have been granted approval to import and administer the Sinopharm vaccine via the special access route by the Health Sciences Authority (HSA) and Ministry of Health (MOH)

TAGS
AsiaMedic
Sinopharm Covid-19 Vaccine

Highlights

Trending Now
DBS CEO Tan Su Shan earns $9.6 mil in FY2025; predecessor Piyush Gupta paid $4.2 mil
US tells tariff refund judge it can’t comply with order
JPMorgan sticks with ‘overweight’ on Singtel as share buybacks begin early
Mastercard, DBS and UOB successfully trial autonomous payment by AI agent in Singapore
Sembcorp refutes reports that its Fujairah 1 plant in UAE damaged; no gas imports from Middle East scheduled this year

Related News

AsiaMedic’s largest individual shareholder raises stake in company to 5.046% of total voting shares
Insider moves

AsiaMedic’s largest individual shareholder raises stake in company to 5.046% of total voting shares

September 22, 2025
AsiaMedic partners with Sunway to establish new diagnostic imaging centre
Healthcare

AsiaMedic partners with Sunway to establish new diagnostic imaging centre

May 15, 2024
Clearbridge Health receives second batch of Sinopharm Covid-19 vaccine
Covid-19

Clearbridge Health receives second batch of Sinopharm Covid-19 vaccine

September 22, 2021
Get market-moving insights before anyone else
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
Topics
Broker's CallsBanking & financeProperty
ResultsContractsAll flash categories
Products & Services
NewsNewsletterVideosOptions
SG60AdvertisingT&CsSitemap
About Us
Our CompanyContact UsEditorial TeamJoin Us
Advertise with usFAQsPrivacy PolicyMalaysiaEvents
© 2026 The Edge Publishing Pte Ltd. All rights reserved.